Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
68.91
+6.22 (9.92%)
At close: May 13, 2025, 4:00 PM
69.94
+1.03 (1.49%)
Pre-market: May 14, 2025, 7:30 AM EDT
Tempus AI Employees
Tempus AI had 2,400 employees as of December 31, 2024. The number of employees increased by 100 or 4.35% compared to the previous year.
Employees
2,400
Change (1Y)
100
Growth (1Y)
4.35%
Revenue / Employee
$334,715
Profits / Employee
-$300,546
Market Cap
11.93B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TEM News
- 15 hours ago - Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025 - Business Wire
- 6 days ago - Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals - Benzinga
- 7 days ago - Tempus AI, Inc. (TEM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Tempus Reports First Quarter 2025 Results - Business Wire
- 8 days ago - Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry - Business Wire
- 12 days ago - Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment - Business Wire
- 14 days ago - Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection - Business Wire
- 15 days ago - Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform - Business Wire